Last update 23 Jan 2025

Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.

Private Company|
2019|
Beijing Shi, China

Overview

Tags

Nervous System Diseases
Digestive System Disorders
Infectious Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Chemical drugs1
Top 5 TargetCount
OOR x μ opioid receptor1

Related

3
Drugs associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
MBT-1316
Target-
Mechanism-
Active Org.
Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Active Indication
Hepatitis B, Chronic
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
HY-1608
Target
OOR x μ opioid receptor
Mechanism
OOR agonists [+1]
Active Org.
Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Active Indication
Pain, Postoperative
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
MBT-1805
Target
PPARδ
Mechanism
PPARδ agonists
Active Org.-
Originator Org.
Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Active Indication-
Inactive Indication
Liver Cirrhosis, Biliary
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
CTR20244082
/ RecruitingPhase 1
单中心、随机、双盲、安慰剂对照评价HY-1608注射液在中国健康成年志愿者中单次给药的安全性、耐受性、药代动力学特征的I期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetic characteristics of a single dose of HY-1608 injection in healthy adult volunteers in China
CTR20232062
/ RecruitingPhase 1
评价MBT-1316 片在健康受试者中单次、多次给药的安全性、耐受性、药代动力学特征及食物影响的Ia 期临床试验
[Translation] Phase Ia clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and food effects of single and multiple doses of MBT-1316 tablets in healthy subjects
CTR20223380
/ RecruitingPhase 1
评价MBT-1316 片在慢性乙型肝炎患者中多剂量单次、多次给药的安全性、耐受性、药效学、药代动力学特征的Ib 期临床试验
[Translation] Phase Ib clinical trial to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetic characteristics of MBT-1316 tablets in patients with chronic hepatitis B after single and multiple doses
100 Clinical Results associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Junke Huayuan Pharmaceutical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HY-1608
 ( OOR x μ opioid receptor )		Pain, Postoperative
More
Phase 1
MBT-1316
Hepatitis B, Chronic
More
Phase 1
MBT-1805
 ( PPARδ )		Liver Cirrhosis, Biliary
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free